The dystroglycanopathies are a set of muscular dystrophies characterized by defects in the glycosylation of α-dystroglycan, a component of the dystrophin-associated glycoprotein complex [1–3]. Here, DAG1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.